sec filing
LX
NASDAQ · LXEO
Lexeo Therapeutics, Inc. Common Stock
Healthcare · Biotechnology
$4.36
Down-$0.11 (-2.52%)
Updated Sep 11, 2026, 9:26 PM
SID Score
4.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 715.64M
- P/E ratio
- -3.74
- Dividend yield
- 0.00%
- 52-week range
- $3.99 – $8.00
- Volume
- 420.87K
- Avg. volume
- 1.28M
Price performance
LXEO price history
1M range · 20 trading sessions · Daily adjusted prices
LXEO closed at $4.36 after 20 trading sessions, down 12.10% for the selected period.
- Last close
- $4.36
- Period change
- -12.10%
- Period low
- $4.36
- Period high
- $5.37
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $4.43 | $4.44 | $4.31 | $4.36 | 420.87K |
| Sep 9, 2026 | $4.72 | $4.805 | $4.48 | $4.48 | 311.69K |
| Sep 8, 2026 | $4.82 | $4.87 | $4.66 | $4.76 | 357.81K |
| Sep 4, 2026 | $4.76 | $4.99 | $4.76 | $4.89 | 296.44K |
| Sep 3, 2026 | $4.80 | $4.92 | $4.67 | $4.84 | 313.34K |
| Sep 2, 2026 | $4.76 | $4.96 | $4.65 | $4.78 | 468.36K |
| Sep 1, 2026 | $4.70 | $4.77 | $4.5639 | $4.70 | 420.48K |
| Aug 31, 2026 | $4.82 | $4.82 | $4.62 | $4.76 | 472.04K |
| Aug 28, 2026 | $4.96 | $4.96 | $4.73 | $4.86 | 663.61K |
| Aug 27, 2026 | $4.97 | $5.09 | $4.885 | $4.99 | 1.11M |
| Aug 26, 2026 | $5.10 | $5.11 | $4.91 | $5.01 | 689.96K |
| Aug 25, 2026 | $4.97 | $5.13 | $4.94 | $5.13 | 937.38K |
| Aug 24, 2026 | $4.88 | $4.965 | $4.70 | $4.92 | 518.5K |
| Aug 21, 2026 | $5.12 | $5.204 | $4.84 | $4.88 | 509.59K |
| Aug 20, 2026 | $5.29 | $5.355 | $4.90 | $5.06 | 1.11M |
| Aug 19, 2026 | $5.07 | $5.405 | $5.05 | $5.37 | 941.95K |
| Aug 18, 2026 | $4.94 | $5.05 | $4.825 | $4.93 | 649.79K |
| Aug 17, 2026 | $4.83 | $5.0259 | $4.82 | $4.98 | 913.84K |
| Aug 14, 2026 | $4.98 | $4.98 | $4.72 | $4.84 | 676.67K |
| Aug 13, 2026 | $4.95 | $5.015 | $4.73 | $4.96 | 1.11M |
Latest LXEO news
The latest Smart Investors Daily articles mentioning LXEO.
Stock researchCompany · Forecast
Loading stock research…